Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

Gut

Volumn 59, Issue 8, 2010, Pages 1056-1065

  Oussalah, Abderrahim ^a   Laurent, Valérie ^a   Bruot, Olivier ^a   Bressenot, Aude ^a   Bigard, Marc André ^a   Régent, Denis ^a   Peyrin Biroulet, Laurent ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARON SCORE; COLITIS; COLON CROHN DISEASE; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; FEMALE; HUMAN; INTESTINE PREPARATION; MAGNETIC RESONANCE COLONOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; WALMSLEY INDEX;

ADULT; BIOLOGICAL MARKERS; CATHARTICS; COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954697161     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.197665     Document Type: Article

References (35)

1. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53 Suppl 5:V1-16.
2. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55 Suppl 1:i1-15.
3. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:2015-22.
4. Rimola J, Rodriguez S, Garcia Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in Crohn disease. Gut 2009;58:1113-20.
5. Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut 2005;54:250-6.
6. Langhorst J, Kuhle CA, Ajaj W, et al. MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis 2007;13:1001-8. (Pubitemid 47309972)
7. Achiam MP, Logager V, Chabanova E, et al. Patient acceptance of MR colonography with improved fecal tagging versus conventional colonoscopy. Eur J Radiol 2010;73:143-7.
8. Laurent V, Trausch G, Bruot O, et al. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol Published Online First:2 Jun 2009. doi:10.1016/j.ejrad.2009.04.059.
9. Kiryu S, Dodanuki K, Takao H, et al. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease. J Magn Reson Imaging 2009;29:880-6.
10. Oto A, Zhu F, Kulkarni K, et al. Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol 2009;16:597-603.
11. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut 1998;43:29-32.
12. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-6.
13. Feagan BG, Greenberg GR, Wild G, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005;352:2499-507.
14. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505-12.
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
16. Hinkle DE, Wiersma W, Jurs SG. Applied statistics for the behavioral sciences. 2nd edn. Boston: Houghton Mifflin Company, 1988.
17. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
18. Shoenut JP, Semelka RC, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;19:31-5.
19. Madsen SM, Thomsen HS, Munkholm P, et al. Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imaging. Scand J Gastroenterol 1998;33:1193-200.
20. Martinez MJ, Ripolles T, Paredes JM, et al. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009;34:141-8.
21. Horsthuis K, Nederveen AJ, de Feiter MW, et al. Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn's disease: a feasibility study. J Magn Reson Imaging 2009;29:488-93.
22. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008;15:153-64.
23. Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008;33:417-24. (Pubitemid 351713068)
24. van Gemert-Horsthuis K, Florie J, Hommes DW, et al. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla. J Magn Reson Imaging 2006;24:340-8. (Pubitemid 44188560)
25. Rottgen R, Herzog H, Lopez-Haninnen E, et al. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn's disease. Clin Imaging 2006;30:27-31. (Pubitemid 41828070)
26. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006;238:517-30. (Pubitemid 43134364)
27. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005;3:1221-8. (Pubitemid 41797674)
28. Ajaj WM, Lauenstein TC, Pelster G, et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 2005;54:257-63.
29. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177:1325-32. (Pubitemid 33081474)
30. Marcos HB, Semelka RC. Evaluation of Crohn's disease using half-fourier RARE and gadolinium-enhanced SGE sequences: initial results. Magn Reson Imaging 2000;18:263-8.
31. Low RN, Francis IR, Politoske D, et al. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127-35. (Pubitemid 30080965)
32. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007;25:373-84.
33. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-35.
34. Choi D, Jin Lee S, Ah Cho Y, et al. Bowel wall thickening in patients with Crohn's disease: CT patterns and correlation with inflammatory activity. Clin Radiol 2003;58:68-74. (Pubitemid 36104944)
35. Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64-79.